News
In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...
The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...
With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...
GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.
GSK plc (NYSE:GSK) is one of the best cheap stocks under $50 to buy now. On July 15, BofA analyst Sachin Jain maintained a ...
The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...
On a quest to bring its multiple myeloma antibody-drug conjugate (ADC) Blenrep back to the U.S. | Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with ocular toxicity side ...
Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback